Materiały źródłowe

• #1

  https://www.nhs.uk/conditions/ulcerative-colitis/treatment/

  Treatment for ulcerative colitis depends on how severe the condition is and how often your symptoms flare-up. […] The main aims of treatment are to: reduce symptoms, known as inducing remission (a period without symptoms) and maintain remission. […] This usually involves taking various types of medicine, although surgery may sometimes be an option. […] Aminosalicylates, also known as 5-ASAs, are medicines that help to reduce inflammation. This in turn allows damaged tissue to heal. […] They’re usually the first treatment option for mild or moderate ulcerative colitis. […] 5-ASAs can be used as a short-term treatment for flare-ups. They can also be taken long term, usually for the rest of your life, to maintain remission. […] Corticosteroids, such as prednisolone, are an alternative type of medicine used to reduce inflammation.

• #1 Ulcerative colitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/ulcerative-colitis/diagnosis-treatment/drc-20353331

  Ulcerative colitis treatment usually involves either drug therapy or surgery. […] Several categories of medicines may be effective in treating ulcerative colitis. The type you take depends on the severity of your condition. The medicines that work well for some people may not work for others, so it may take time to find a medicine that helps you. […] In addition, because some medicines have serious side effects, you need to weigh the benefits and risks of any treatment. […] Anti-inflammatory medicines are often the first step in the treatment of ulcerative colitis and are appropriate for many people with this condition. […] These medicines include: Oral 5-aminosalicylates. Examples of this type of medicine include sulfasalazine (Azulfidine), mesalamine (Delzicol, Lialda, others), balsalazide (Colazal) and olsalazine (Dipentum).

• #1 Study finds new treatment for ulcerative colitis

  https://medicalxpress.com/news/2024-06-treatment-ulcerative-colitis.html

  Study finds new treatment for ulcerative colitis […] A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago Medicine’s David T. Rubin, MD, Professor of Medicine and Chief of the Section of Gastroenterology, Hepatology and Nutrition. […] The medication, guselkumab (Tremfya), is an antibody that blocks IL-23, the cytokine that drives many immune diseases, including ulcerative colitis. It can be administered as an injection or through an infusion. […] The Phase III QUASAR maintenance study showed that Tremfya can achieve symptomatic remission and also bowel healing, with a notably high rate of this important endpoint, Rubin said. The unique bowel healing capabilities help keep the disease in remission.

• #1 Ulcerative Colitis Treatments – MPR

  https://www.empr.com/charts/ulcerative-colitis-treatments/

  Ulcerative Colitis Treatments […] MILDLY TO MODERATELY ACTIVE DISEASE Aminosalicylate balsalazide disodium Colazal 750mg caps Adults: 2.25g 3 times daily for 8wks; max 12wks. Children: 5yrs: not recommended. 5yrs: 2.25g 3 times daily or 750mg 3 times daily; max 8wks. mesalamine 800mg del-rel tabs Adults: 1600mg 3 times daily for 6wks. Children: Not established. Apriso 0.375g ext-rel caps Adults: Maintenance: 1.5g once daily in the AM. Children: Not established. Canasa 1g supp Adults: 1g once daily at bedtime for 36wks. Retain supp in rectum for at least 13hrs. Children: Not established. Delzicol 400mg del-rel caps Adults: 800mg 3 times daily for 6wks. Maintenance: 1.6g daily in 24 divided doses. Do not substitute two Delzicol 400mg caps with one mesalamine 800mg del-rel tab. Children: 5yrs: not established. Give twice daily for 6wks. 5yrs (1732kg): 3671mg/kg/day, up to max 1.2g/day (800mg in AM + 400mg in the afternoon); (3353kg): 3761mg/kg/day, up to max 2g/day (1200mg in AM + 800mg in the afternoon); (5490kg): 2744mg/kg/day, up to max 2.4g/day (1200mg in AM + 1200mg in the afternoon). Lialda 1.2g del-rel tabs Adults: Induction: 2.44.8g once daily. Maintenance: 2.4g once daily. Children: 24kg: not established. Take once daily. 2435kg (Weeks 0 to 8): 2.4g; (after Week 8): 1.2g. 3550kg (Weeks 0 to 8): 3.6g; (after Week 8): 2.4g. 50kg (Weeks 0 to 8): 4.8g; (after Week 8): 2.4g. Pentasa 250mg, 500mg controlled-rel caps Adults: 1g four times daily for up to 8wks. Children: Not established. Rowasa 4g/60mL enema Adults: 4g (60mL) daily at bedtime for 36wks. Retain enema for 8hrs. Children: Not established. olsalazine sodium Dipentum 250mg caps Adults: Maintenance: 500mg twice daily with meals. Children: Not established. sulfasalazine Azulfidine 500mg scored tabs Adults: Initially 12g daily, increase gradually to 34g daily in equally divided doses after meals until symptoms controlled. Maintenance: 2g daily; max 4g/day. Children: 6yrs: not established. 6yrs: initially 4060mg/kg/day in 36 doses. Maintenance: 30mg/kg/day in 4 doses. Azulfidine EN-tabs 500mg e-c tabs Corticosteroid1 budesonide Uceris2 9mg ext-rel tabs Adults: Remission induction: 9mg once daily in the AM for up to 8wks. Children: Not established. Uceris Rectal Foam3 2mg emulsion Adults: Remission induction: apply 1 metered dose per rectum twice daily (AM PM) for 2wks, then 1 metered dose once daily (PM) for 4wks. Children: Not established.

• #1 Current Pharmacologic Options and Emerging Therapeutic Approaches for the Management of Ulcerative Colitis: A Narrative Review | Published in Spartan Medical Research Journal

  https://smrj.scholasticahq.com/article/123397-current-pharmacologic-options-and-emerging-therapeutic-approaches-for-the-management-of-ulcerative-colitis-a-narrative-review

  The management of UC concentrates on minimizing the resurgence or exacerbation of symptoms related to the condition, limiting the necessity of using steroids, as well as safeguarding the bowel mucosa by suppressing the formation of ulcers, which would facilitate healing, thereby lowering the risk of infections, hospitalizations, indirectly promote patient satisfaction by enhancing the quality of life, and diminish the need for surgical interventions. […] SASP is a disease-modifying antirheumatic drug (DMARD) that is used to treat several inflammatory conditions like UC. […] The efficiency of SASP has been studied extensively, and a comparison of the drug against other pharmacological treatment options for UC is necessary to provide the most up-to-date treatment guidelines. […] Newer salicylate-based drugs with fewer side effects have been developed and started using it for UC treatment lately. These are free of the sulfur component and are composed of 5-ASA without the sulfapyridine carrier molecule. Mesalamine, also known as mesalazine or (5-ASA), is one of the currently available 5-ASA-based agents used for the treatment of UC.

• #1 Ulcerative Colitis (UC): Symptoms, Causes, Treatment, and More

  https://www.medicalnewstoday.com/articles/163772

  Ulcerative colitis is a relatively common long-term condition that causes inflammation in the colon. Dietary changes and medications can often help manage symptoms, but surgery is an option in severe cases. […] Various medication options can help reduce symptoms, and doctors can tailor treatment to meet individual needs. […] Treatment usually focuses on maintaining remission to prevent further symptoms and managing a flare until symptoms go into remission. […] Various medications are available, and a doctor will make a treatment plan that accounts for a person’s individual needs and wishes. Natural approaches can support medical treatment but cannot replace it. […] Treatment for UC can include: Aminosalicylates such as mesalamine, balsalazide, and sulfasalazine, which are drugs that target inflammation in the lining of the colon. Corticosteroids, which are powerful, fast-acting anti-inflammatories that can treat UC flare-ups. Immunomodulators, which are drugs that regulate the immune system, such as thiopurines (azathioprines) and methotrexate. Biologics, which target inflammation in the gut. These can include TNF-alpha antagonists such as infliximab (Remicade) and adalimumab (Humira), anti-integrin agents such as vedolizumab (Entyvio), and interleukin 12/23 antagonists such as ustekinumab (Stelara). Targeted synthetic small molecules, which can reduce inflammation. Options can include Janus kinase (JAK) inhibitors such as tofacitinib (Xeljanz) and upadacitinib (Rinvoq).

• #1 Management of mild-to-moderate ulcerative colitis – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/management-of-mild-to-moderate-ulcerative-colitis/

  Best practices for managing patients with mild-to-moderate ulcerative colitis (UC), focusing on use of both oral and topical 5-aminosalicylates (5-ASA) medications, rectal corticosteroids and oral budesonide. […] 1. In patients with extensive mild–moderate ulcerative colitis (UC), AGA recommends using either standard-dose mesalamine (2–3 g/d) or diazo-bonded 5-aminosalicylates (5-ASA) rather than low-dose mesalamine, sulfasalazine, or no treatment. 2. In patients with extensive or left-sided mild–moderate UC, AGA suggests adding rectal mesalamine to oral 5-ASA. 3. In patients with mild–moderate UC with suboptimal response to standard-dose mesalamine or diazo-bonded 5-ASA or with moderate disease activity, AGA suggests using high-dose mesalamine (>3 g/d) with rectal mesalamine. 4. In patients with mild–moderate UC being treated with oral mesalamine, AGA suggests using once-daily dosing rather than multiple times per day dosing. 5. In patients with mild–moderate UC, AGA suggests using standard-dose oral mesalamine or diazo-bonded 5-ASA, rather than budesonide MMX or controlled ileal release budesonide for induction of remission. 6. In patients with left-sided mild–moderate ulcerative proctosigmoiditis or proctitis, AGA suggests using mesalamine enemas (or suppositories) rather than oral mesalamine. 7. In patients with mild–moderate ulcerative proctosigmoiditis who choose rectal therapy over oral therapy, AGA suggests using mesalamine enemas rather than rectal corticosteroids. 8. In patients with mild–moderate ulcerative proctitis who choose rectal therapy over oral therapy, AGA recommends using mesalamine suppositories. 9. In patients with mild–moderate ulcerative proctosigmoiditis or proctitis being treated with rectal therapy who are intolerant of or refractory to mesalamine suppositories, AGA suggests using rectal corticosteroid therapy rather than no therapy for induction of remission. 10. In patients with mild–moderate UC refractory to optimized oral and rectal 5-ASA, regardless of disease extent, AGA suggests adding either oral prednisone or budesonide MMX. 11. In patients with mild–moderate UC, AGA makes no recommendation for use of probiotics. 12. In patients with mild–moderate UC despite 5-ASA therapy, AGA makes no recommendation for use of curcumin. 13. In patients with mild–moderate UC without Clostridium difficile infection, AGA recommends fecal microbiota transplantation be performed only in the context of a clinical trial.

• #1 Ulcerative colitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/ulcerative-colitis/diagnosis-treatment/drc-20353331

  Corticosteroids. These medicines, which include prednisone and budesonide, are generally reserved for moderate to severe ulcerative colitis that doesn’t respond to other treatments. Due to the side effects, they are not usually given long term. […] These medicines also reduce inflammation, but they do so by suppressing the immune system response that starts the process of inflammation. […] Immunomodulators include: Azathioprine (Azasan, Imuran) and mercaptopurine (Purinethol, Purixan). […] This class of therapies targets proteins made by the immune system. […] Types of biologics used to treat ulcerative colitis include: Infliximab (Remicade), adalimumab (Humira) and golimumab (Simponi). […] More recently, orally delivered agents also known as „small molecules” have become available for ulcerative colitis treatment.

• #1 Ulcerative Colitis: Diagnosis and Treatment | AAFP

  https://www.aafp.org/pubs/afp/issues/2007/1101/p1323.html/1000

  For patients who fail to improve with the maximal dosage of 5-ASA compounds or who cannot tolerate the side effects, oral steroid therapy should be considered. […] When patients do not respond to orally administered steroids, they should be admitted to the hospital to receive intravenous corticosteroids, such as methylprednisolone sodium (Solu-Medrol), 40 mg daily. […] In two recent clinical trials, 60 percent of patients who failed to respond to corticosteroid therapy achieved symptom remission with infliximab (Remicade), a chimeric monoclonal antibody that neutralizes the proinflammatory cytokine tumor necrosis factor-, compared with approximately 30 percent of patients who received placebo. […] The level of therapy that induces remission dictates the selection of maintenance therapy. Patients who achieve remission solely with 5-ASA compounds may remain on these same medications, although typically at lower dosages.

• #1 Ulcerative Colitis Treatment & Management: Approach Considerations, Treatment of Mild Disease, Treatment of Acute, Severe Disease

  https://emedicine.medscape.com/article/183084-treatment

  As yet, no evidence suggests that regular endoscopic screening of patients with UC improves survival. However, the current standard of practice by many gastroenterologists is to continue screening these patients at regular intervals, owing to the risk of cancer development and possible legal implications if malignancy is not detected. […] In mild UC disease confined to the rectum, topical mesalazine (Asacol) given by suppository is the preferred therapy. […] Systemic steroids are indicated when the disease fails to quickly respond to aminosalicylates. […] In January 2013, the US Food and Drug Administration (FDA) approved an extended-release oral formulation of budesonide for the treatment of active mild-to-moderate UC in adults patients. […] Acute, severe UC (ie, 6 bloody bowel movements/day, with one of the following: fever 38C [100.4F], hemoglobin level 10.5 g/dL, heart rate 90 bpm, erythrocyte sedimentation rate 30 mm/h, or C-reactive protein level 30 mg/dL) requires hospitalization and treatment with intravenous high-dose corticosteroids (hydrocortisone 400 mg/d or methylprednisolone 60 mg/d).

• #1 Ulcerative Colitis: Current and Emerging Treatment Strategies

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7019865/

  Second-line therapies for patients with mild-moderate UC who do not respond to mesalamine are corticosteroids. […] As of this writing, agents currently approved for the induction and maintenance of remission of moderate-severe UC include the biologics infliximab, adalimumab, golimumab, vedolizumab, and ustekinumab, in addition to the small-molecule Janus kinase (JAK) inhibitor tofacitinib. […] Currently approved medical therapies for patients hospitalized with ASUC are steroids, infliximab, and cyclosporine. […] Systemic steroids administered as methylprednisolone 20 mg intravenously every eight hours, or equivalent, are still the mainstay as the initial therapy for hospitalized patients with ASUC. […] Infliximab is a TNF inhibitor with a rapid onset of action. […] Cyclosporine directly inhibits calcineurin, a component of cytokine gene transcription, and downregulates IL-2, IL-3, IL-4, and TNF-alpha.

• #1 Management of ulcerative colitis – Wikipedia

  https://en.wikipedia.org/wiki/Management_of_ulcerative_colitis

  Corticosteroids should not be used for long-term therapy of UC, particularly without the concomitant use of an immunomodulator or anti-TNF. […] Immunosuppressive drugs inhibit the immune system generally. […] TNF is a protein that is released by activated white blood cells, triggering more inflammation, an immune system response and more damage to the mucosa of the colon because of the immune activation. […] Standard treatment for active disease includes Mesalazine suppositories and cortisone foam (Cortifoam). […] Maintenance therapy is with Mesalazine 1g QHS or Q3HS. […] Patients usually require a combination of oral Mesalazine or sulfasalazine along with topical Mesalazine or steroid enemas. […] Patients need to be hospitalized immediately with subsequent bowel rest, nutrition, and IV steroids.

• #1

  https://www.nhs.uk/conditions/ulcerative-colitis/treatment/

  They can be used with or instead of 5-ASAs to treat a flare-up if 5-ASAs alone are not effective. […] Immunosuppressants, such as tacrolimus and azathioprine, are medicines that reduce the activity of the immune system. […] They’re usually given as tablets to treat mild or moderate flare-ups, or maintain remission if your symptoms have not responded to other medicines. […] While mild or moderate flare-ups can usually be treated at home, more severe flare-ups should be managed in hospital to minimise the risk of dehydration and potentially fatal complications, such as your colon rupturing. […] Biologic medicines are medicines that reduce inflammation of the intestine by targeting proteins the immune system uses to stimulate inflammation. […] These medicines may be used to treat moderate to severe ulcerative colitis if other options are not suitable or not working.

• #1 Treatment for Ulcerative Colitis | Evinature

  https://evinature.com/blog/gut-health/treatment-for-ulcerative-colitis/

  Immunosuppressants such as 6-mercaptopurine, azathioprine, and methotrexate treat ulcerative colitis by suppressing the immune systems response. […] Biologics are another type of immunosuppressant. […] Where medications fail, or if a flare of UC is so severe it may put a patients life at risk, gastroenterologists may advise a surgeon to remove the colon. […] This surgery is only for the most severe cases of ulcerative colitis, where other medical interventions have failed to reduce inflammation. […] Although UC is a chronic disease, remission is achievable through coordination with your doctor and maintaining a healthy lifestyle. […] Many UC patients also turn to complementary or alternative medicine (CAM) to help manage symptoms. […] Curcumin is the active ingredient in turmeric root used in Ayurveda and Traditional Chinese Medicine for thousands of years to treat gut disorders due to its potent anti-inflammatory and antioxidant properties.

• #1 Ulcerative Colitis Treatment & Management: Approach Considerations, Treatment of Mild Disease, Treatment of Acute, Severe Disease

  https://emedicine.medscape.com/article/183084-treatment

  A systematic review and meta-analysis comprising eight randomized controlled studies of biologics in patients with inflammatory bowel disease found that primary nonresponse to anti-tumor necrosis factor (anti-TNF) agents was associated with an inferior response to second-line non-TNF biologics, relative to therapy discontinuation owing to secondary loss of response after initial response or intolerance. […] Cyclosporine is effective for inducing remission in severely active and refractory UC, with an efficacy equivalent to that of infliximab. […] Once remission has been achieved, maintenance therapy is recommended for all patients with UC to prevent relapse. […] Oral aminosalicylates are indicated for disease that responded to acetylsalicylic acid (ASA) or steroids. […] Anti-tumor necrosis factor (anti-TNF) agents are effective for the induction of remission in steroid-refractory or steroid-dependent moderate to severe UC. […] Corticosteroids may be used for induction of remission of active UC and continued for up to 8 weeks; however, these agents have no efficacy for maintenance of remission and should not be used for this purpose. […] Probiotics also appear to be effective at maintaining remission.

• #1 Ulcerative Colitis Treatments and Surgery

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/digestive-diseases-ulcerative-colitis-treatment

  Treatment for ulcerative colitis can include medicines, changes in diet, or surgery. These UC treatments won’t cure ulcerative colitis unless you have surgery that removes the colon and rectum, which is considered curative, but they can help ease your symptoms. […] Your doctor may suggest several types of colitis medications to curb inflammation in your bowel, including sulfa drugs, corticosteroids, immunosuppressive agents, and antibiotics. […] Balsalazide, mesalamine, olsalazine, and sulfasalazine are the main medications you take to treat ulcerative colitis. […] You can use these anti-inflammatory drugs if 5-ASA drugs don’t work or if you have a more severe disease. […] If corticosteroids or 5-ASA drugs don’t help, your doctor may prescribe other drugs such as 6-mercaptopurine (6-MP), azathioprine (Azasan, Imuran), cyclosporine, and tacrolimus (Astagraf XL, Envarsus XR, Prograf).

• #1

  https://www.healthshare.com.au/questions/45381-what-are-the-treatment-options-for-someone-with-ulcerative-colitis/

  If the disease is severe and not improving with prednisolone, often an admission to hospital for intravenous corticosteroids is required and in very severe cases, other treatments such as cyclosporin or infliximab may be needed. […] Once the initial or acute episode comes into remission, we usually continue the 5-ASA agent. If there is a frequent need for prednisolone or a hospital admission is required to treat a severe flare, then an immunosuppressant agent such as azathioprine (Imuran) or 6-mercaptopurine (Puri-Nethol) is then started to try to keep the patient in remission and avoid the need for more prednisolone. […] In some patients surgery is needed. This is removal of the whole colon either because of very severe disease at risk of colon rupture, ongoing difficult to control disease despite large doses of medications or long standing UC with some changes in the bowel that increase the risk of developing bowel cancer. Over the lifetime of the illness, this is required in between 15-25% of patients.

• #1 Ulcerative Colitis Treatments – MPR

  https://www.empr.com/charts/ulcerative-colitis-treatments/

  MODERATELY TO SEVERELY ACTIVE DISEASE Integrin Receptor Antagonist vedolizumab4 Entyvio 300mg/vial pwd for IV infusion after reconstitution Adults: IV regimen: infuse over 30mins. 300mg IV at Weeks 0, 2, and 6, then every 8wks thereafter. SC regimen: give SC inj into thighs, abdomen, or upper arms. After the first 2 IV doses given (Week 0 and Week 2), may be switched to 108mg SC every 2wks at Week 6 and thereafter. For those with clinical response or remission beyond Week 6, may be switched from IV infusion to SC inj. For both regimens: discontinue if no therapeutic benefit by Week 14. Adults: Not established. 108mg/0.68mL soln for SC inj Interleukin-12 and Interleukin-23 Antagonist ustekinumab Stelara 130mg/26mL soln for IV infusion after dilution Adults: Induction: give as a single IV infusion over 1hr. 18yrs (55kg): 260mg; (5585kg): 390mg; (85kg): 520mg. Maintenance: 90mg SC given 8wks after initial IV dose, then every 8wks thereafter. Children: Not established. 45mg/0.5mL, 90mg/mL soln for SC inj Interleukin-23 Antagonist mirikizumab Omvoh 20mg/mL soln for IV infusion after dilution Adults: Induction: infuse over 30mins. 300mg at Week 0, Week 4, and Week 8. Maintenance: 200mg SC (two 100mg injs; use different sites every time) at Week 12, and every 4wks thereafter. Children: Not established. 100mg/mL soln for SC inj risankizumab Skyrizi 90mg/mL, 150mg/mL soln for SC inj Adults: Induction: 1200mg by IV infusion over 2hrs at Week 0, Week 4, and Week 8. Maintenance: 180mg or 360mg SC into thigh or abdomen (using the on-body injector) at Week 12, and every 8wks thereafter. Children: Not established. 60mg/mL soln for IV infusion after dilution Janus Kinase Inhibitor tofacitinib5 Xeljanz 5mg, 10mg tabs Adults: 10mg twice daily for 8wks, then 5mg twice daily. May continue 10mg twice daily dose for up to max 16wks if needed; limit to those with loss of response. Discontinue after 16wks if inadequate response with 10mg twice daily. Children: Not established. Xeljanz XR 11mg, 22mg ext-rel tabs Adults: 22mg once daily for 8wks, then 11mg once daily. May continue 22mg once daily dose for up to max 16wks if needed; limit to those with loss of response. Discontinue after 16wks if inadequate response with 22mg once daily. Children: Not established. upadacitinib Rinvoq5 15mg, 30mg, 45mg ext-rel tabs Adults: Induction: 45mg once daily for 8wks. Maintenance: 15mg once daily; may consider 30mg once daily for refractory, severe or extensive disease (discontinue if inadequate response with 30mg dose). Severe renal impairment (CrCl 1530mL/min), mild to moderate hepatic impairment, concomitant strong CYP3A4 inhibitors: 30mg once daily for 8wks (induction); 15mg once daily (maintenance). Children: Not established. Sphingosine 1-Phosphate Receptor Modulator etrasimod Velsipity 2mg tabs Adults: 2mg once daily. Children: Not established. ozanimod Zeposia 0.23mg, 0.46mg, 0.92mg caps Adults: Initiate dose titration regimen (Days 14): 0.23mg once daily; (Days 57): 0.46mg once daily. Maintenance (starting Day 8): 0.92mg once daily. Re-initiation after dose interruption (during 1st 2wks): start with Day 1 of titration regimen; (after the 1st 2wks): continue treatment as planned. Mild or moderate hepatic impairment: 0.92mg once every other day starting on Day 8 after initial titration. Children: Not established. TNF-Alpha Blocker adalimumab Humira 10mg/0.1mL, 10mg/0.2mL, 20mg/0.2mL, 20mg/0.4mL, 40mg/0.4mL, 40mg/0.8mL, 80mg/0.8mL soln for SC inj Adults: Initially 160mg SC on Day 1 (in 1 day or divided over 2 days), then 80mg on Day 15. Maintenance: on Day 29, start 40mg every other week. May continue aminosalicylates, corticosteroids, or immunomodulatory agents. Discontinue in those without evidence of clinical remission by 8wks of therapy. Children: 5yrs: not recommended. 5yrs (2040kg): initially 80mg SC on Day 1, then 40mg on Day 8 and Day 15. Maintenance: on Day 29, start 40mg every other week or 20mg every week. 40kg: initially 160mg on Day 1 (given in 1 day or divided over 2 days), then 80mg on Day 8 and Day 15. Maintenance: on Day 29, start 80mg every other week or 40mg every week. Continue recommended pediatric dose in those who turn 18yrs of age and are well-controlled. Abrilada 10mg/0.2mL, 20mg/0.4mL, 40mg/0.8mL soln for SC inj Adults: Initially 160mg SC on Day 1 (in 1 day or divided over 2 days), then 80mg on Day 15. Maintenance: on Day 29, start 40mg every other week. May continue aminosalicylates, corticosteroids, or immunomodulatory agents. Discontinue in those without evidence of clinical remission by 8wks of therapy. Children: Not established. Amjevita 10mg/0.2mL, 20mg/0.2mL, 20mg/0.4mL, 40mg/0.4mL, 40mg/0.8mL, 80mg/0.8mL Cyltezo 10mg/0.2mL, 20mg/0.4mL, 40mg/0.4mL, 40mg/0.8mL Hadlima 40mg/0.4mL (citrate-free), 40mg/0.8mL Hulio 20mg/0.4mL, 40mg/0.8mL Hyrimoz 10mg/0.1mL, 10mg/0.2mL, 20mg/0.2mL, 20mg/0.4mL, 40mg/0.4mL, 40mg/0.8mL, 80mg/0.8mL Idacio 40mg/0.8mL (citrate-free) Simlandi 40mg/0.4mL Yuflyma 20mg/0.2mL, 40mg/0.4mL, 80mg/0.8mL (all citrate-free) Yusimry 40mg/0.8mL golimumab6 Simponi 50mg/0.5mL, 100mg/mL soln for SC inj Adults: Initially 200mg SC at Week 0, followed by 100mg at Week 2, then 100mg every 4wks. 18yrs: Not established. infliximab Remicade 100mg/vial pwd for IV infusion after reconstitution and dilution Adults: Infuse over 2hrs. 5mg/kg at Weeks 0, 2, 6, then once every 8wks. Heart failure: max 5mg/kg. Children: 6yrs: Not established. 6yrs: Same as adult dose. Avsola Inflectra Renflexis Zymfentra 120mg/mL soln for SC inj Adults: For maintenance treatment only (Week 10 and thereafter); must complete IV induction regimen with an infliximab product prior to starting Zymfentra. 120mg SC once every 2wks. Children: Not established.

• #1 HUMIRA® (adalimumab) for Ulcerative Colitis (UC)

  https://www.humira.com/ulcerative-colitis

  HUMIRA is a prescription medicine used to treat moderate to severe ulcerative colitis (UC) in adults and children 5 years of age and older. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate TNF-blocker medicines. […] HUMIRA is a prescription medicine used to treat moderate to severe ulcerative colitis in adults and children 5 years of age and older. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate TNF-blocker medicines. […] To treat moderate to severe ulcerative colitis (UC) in adults and children 5 years of age and older. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate anti-TNF medicines.

• #1 Ulcerative Colitis Treatments and Surgery

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/digestive-diseases-ulcerative-colitis-treatment

  This group of drugs includes adalimumab (Humira), plus adalimumab-atto (Amjevita) and adalimumab-adbm (Cyltezo), which are biosimilars to Humira; certolizumab pegol (Cimzia), golimumab (Simponi, Simponi Aria), infliximab (Remicade), infliximab-abda (Renflexis), infliximab-axxq (Avsola), infliximab-dyyb (Inflectra) a biosimilar to Remicade, infliximab-qbtx (IXIFI), ustekinumab (Stelara), and vedolizumab (Entyvio). […] Tofacitinib (Xeljanz) is the first JAK inhibitor that is FDA-approved for the treatment of ulcerative colitis. […] Ozanimod (Zeposia), an oral medication, is the first sphingosine 1-phosphate (S1P) receptor modulator approved for patients with moderately to severely active UC. […] Your doctor may suggest the following diet changes depending on your symptoms: Avoid dairy.

• #1 Achieve Results with ENTYVIO® Treatment for Ulcerative Colitis

  https://www.entyvio.com/ulcerative-colitis

  In two clinical trials, ENTYVIO delivered results for adults with moderate to severe ulcerative colitis when other medicines had not worked well enough or could not be tolerated. […] The first study evaluated response to ENTYVIO versus placebo at Week 6. The second study included adults who had a previous response to ENTYVIO at Week 6 and evaluated remission at Week 52. […] At 6 weeks of treatment, 47% of people on ENTYVIO infused intravenously achieved response compared to 26% of people on placebo. […] 42% of people on ENTYVIO infused intravenously achieved remission at 1 year of treatment, compared to 16% of people on placebo. […] A separate clinical study evaluated remission at Week 52 in adult patients with moderate to severe UC who were administered ENTYVIO subcutaneously vs placebo.

• #1 Study led by UChicago Medicine physician finds new treatment for ulcerative colitis – UChicago Medicine

  https://www.uchicagomedicine.org/forefront/gastrointestinal-articles/2024/june/study-finds-new-ulcerative-colitis-treatment

  A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago Medicines David T. Rubin, Professor of Medicine and Chief of the Section of Gastroenterology, Hepatology and Nutrition. […] The Phase III QUASAR maintenance study showed that Tremfya can achieve symptomatic remission and also bowel healing, with a notably high rate of this important endpoint, Rubin said. […] Nearly 50% of the patients in this maintenance study were in clinical remission after 44 weeks, meaning most or all of the diseases symptoms were gone, and 69% achieved endoscopic remission, meaning the physician saw no signs of inflammation, ulcers or bleeding in the bowel. […] It worked extremely well and maintained a clear response and remission, Rubin said.

• #1 Weighing the new approaches to treating Crohn’s and ulcerative colitis – Harvard Health

  https://www.health.harvard.edu/blog/weighing-the-new-approaches-to-treating-crohns-and-ulcerative-colitis-202210312841

  Anti-TNF alpha therapies: These medications block a protein called tumor necrosis factor (TNF) to reduce inflammation, and are used in both CD and UC patients. Infliximab and adalimumab are some examples of anti-TNF drugs. […] […] Anti-IL-12/23: These therapies reduce intestinal inflammation by inhibiting specific pro-inflammatory proteins called interleukin-12 and interleukin-23. Ustekinumab is FDA-approved to treat both UC and CD. […] […] Anti-Integrin: These medications block white blood cells that cause inflammation from entering the GI tract. Vedolizumab has been shown to be an effective treatment that is tolerated well in IBD patients. […] […] Small molecules: This newer class of medications uses molecules that are small enough to easily enter cells in order to modify different inflammatory pathways in the body. One advantage to these treatments is that they are orally administered, and therefore may be more convenient for patients. […]

• #1 Long-Term Maintenance Therapy for Ulcerative Colitis

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/long-term-maintenance-therapy-uc

  Common medicines for UC thats mild to moderate are aminosalicylates that you take in oral form (tablets or capsules) or topical form (enema or suppository). Theyre also called 5-ASAs. They help reduce the inflammation in the lining of the intestines. If your UC got better with this type of medicine or steroids, you might keep taking medicine with 5-ASA for your maintenance therapy. […] Other medicines for UC work by suppressing the immune system. Theyre called immune modulators. Doctors usually dont suggest these unless aminosalicylates and steroids arent working. […] These are medications that target specific parts of the immune system to help reduce inflammation. They can be used to treat moderately to severely active UC and then can be continued as maintenance. […] If your UC is more severe or doesnt get better with other medicines, you might take a biologic for it. Biologics and biosimilars are genetically engineered proteins that target your immune system in different ways to treat UC or other conditions. Once your UC is in remission, you may keep taking your biologic medicine as a long-term maintenance therapy.

• #1 Ulcerative colitis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/ulcerative-colitis/diagnosis-treatment/drc-20353331

  Types of small molecule medicines include: Tofacitinib (Xeljanz), upadacitinib (Rinvoq) and filgotinib (Jyseleca). […] You may need additional medicines to manage specific symptoms of ulcerative colitis. […] Surgery can eliminate ulcerative colitis and involves removing your entire colon and rectum. […] In most cases, proctocolectomy involves another procedure called ileoanal anastomosis (J-pouch) surgery. […] In some cases, a pouch is not possible. Instead, surgeons create a permanent opening in the belly, called an ileal stoma, through which stool is passed for collection in an attached bag. […] You will likely need more-frequent screening for colon cancer because of your increased risk.

• #1 RINVOQ® (upadacitinib) for Ulcerative Colitis (UC)

  https://www.rinvoq.com/ulcerative-colitis

  In clinical studies, RINVOQ helped people living with UC experience remission at 8 weeks and 1 year. […] RINVOQ helped deliver: RAPID relief from UC symptoms (fewer bowel movements and bloody stools) in as early as 2 weeks. […] POWERFUL results: No bowel urgency, no abdominal pain, and significantly reduced fatigue at 8 weeks. […] Steroid-free remission at 1 year. […] Visible colon lining repair even at 1 year. […] LONG-TERM results: In another study, many people were in remission, even at ~3 years. […] RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated. […] It is not known if RINVOQ is safe and effective in children with ulcerative colitis.

• #1 Drug treatments for Crohn’s Disease and Ulcerative Colitis

  https://crohnsandcolitis.org.uk/info-support/information-about-crohns-and-colitis/all-information-about-crohns-and-colitis/treatments

  Information about adalimumab, a treatment option for people with Crohn’s Disease or Ulcerative Colitis. […] Information about filgotinib (Jyseleca) for Ulcerative Colitis. […] Information about ozanimod (Zeposia) for Ulcerative Colitis. […] Information about 5-ASAs, also known as aminosalicylates, which are used to treat mild to moderate Colitis, and occasionally Crohns. […] Information about tofacitinib (also called Xeljanz), a medicine sometimes used to treat Colitis. […] Information about ustekinumab, a biologic medicine sometimes used to treat Crohns or Colitis. […] Information about vedolizumab (also called Entyvio), a medicine sometimes used to treat Crohn’s or Colitis.

• #1 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  These drugs work in a variety of ways to suppress the immune response that releases inflammation-inducing chemicals into the body. When released, these chemicals can damage the lining of the digestive tract. […] More recently, medicines given by mouth that are known as small molecules have become available for IBD treatment. Janus kinase inhibitors, also called JAK inhibitors, are a type of small molecule medicine that helps reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. Some JAK inhibitors for IBD include tofacitinib (Xeljanz) and upadacitinib (Rinvoq). […] Ozanimod (Zeposia) is another type of small molecule medicine available for IBD. Ozanimod is a medicine known as a sphingosine-1-phosphate receptor modulator, also called an S1P receptor modulator.

• #1 Weighing the new approaches to treating Crohn’s and ulcerative colitis – Harvard Health

  https://www.health.harvard.edu/blog/weighing-the-new-approaches-to-treating-crohns-and-ulcerative-colitis-202210312841

  JAK inhibitors: These therapies interfere with the activity of Janus kinases (JAK), which normally work to stimulate the body’s inflammatory response. Tofacitinib has been approved for the treatment of moderate to severe UC, and is being investigated in CD. […] […] S1P receptor modulators: This class of medication blocks the receptor of a signaling fat molecule called S1P, in order to reduce inflammation and the immune response. Ozanimod was approved in May of 2021 for the treatment of moderate to severe UC. […] […] Corticosteroids: The use of oral corticosteroids such as prednisone was once a mainstay of IBD treatment, but now is typically reserved for short-term usage for patients with active flare symptoms. […] […] Immunomodulators: These medications reduce inflammation in the gastrointestinal tract by suppressing the immune system, and can be effective in treating both CD and UC. […]

• #1

  https://www.nhs.uk/conditions/ulcerative-colitis/treatment/

  JAK inhibitors may be recommended for people with moderate to severe ulcerative colitis if standard treatments or biologics have not worked, or are not suitable. […] A medicine called ozanimod may be recommended for people with moderate to severe ulcerative colitis if standard treatments or biologic medicines have not worked or are not suitable. […] If you have frequent flare-ups that have a significant effect on your quality of life, or you have a particularly severe flare-up that’s not responding to medicines, surgery may be an option. […] Surgery for ulcerative colitis involves permanently removing the colon (a colectomy). […] As the colon is removed, ulcerative colitis cannot come back again after surgery.

• #1 Treatment for Ulcerative Colitis – NIDDK

  https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis/treatment

  Your doctor may recommend surgery if you have colorectal cancer, dysplasia, or precancerous cells that increase the risk for developing colorectal cancer, complications that are life-threatening, such as severe rectal bleeding, toxic megacolon, or perforation of the large intestine, symptoms that dont improve or stop after treatment with medicines, symptoms that only improve with continuous treatment with corticosteroids, which may cause serious side effects when used for a long time. […] To treat ulcerative colitis, surgeons typically remove the colon and rectum and change how your body stores and passes stool. […] If you are considering surgery to treat ulcerative colitis, talk with your doctor or surgeon about what type of surgery might be right for you and the possible risks and benefits.

• #1 Ulcerative Colitis (UC) Symptoms, Treatment, Causes, Diagnosis

  https://www.medicinenet.com/ulcerative_colitis/article.htm

  Surgery in ulcerative colitis is reserved for the following patients: Patients with fulminant colitis and toxic megacolon who are not responding readily to medications. Patients with long-standing pancolitis or left-sided colitis are at risk of developing colon cancers. Removal of the colon is important when changes are detected in the colon lining. Patients who have had years of severe colitis which has responded poorly to medications. […] Treatment by disease severity and location (based on ACG Practice Guidelines): Mild-moderate distal colitis: Oral aminosalicylates, topical mesalamine, or topical steroids. A combination of oral and topical aminosalicylates is better than either alone. For refractory cases, oral steroids or IV infliximab can be used (though this is less well-studied in distal colitis). Mild-moderate extensive colitis: Oral sulfasalazine 4-6 g/day or alternative aminosalicylate 4.8 g/day. Oral steroids for patients refractory to the above therapy + topical therapy. 6-MP or azathioprine for patients refractory to oral steroids, but not so severe as to require IV therapy. Infliximab in patients who are steroid refractory/dependent on adequate doses of 6-MP/thiopurine or who are intolerant to these medications. Severe colitis: Infliximab if urgent hospitalization is not needed. If a patient is toxic, should be admitted to the hospital for IV steroids. Failure to improve in 3-5 days is an indication of colectomy or IV cyclosporine. Maintenance 6-MP can also be added to these patients. […] Absolute indications for surgery: Hemorrhage, perforation, documented or strongly suspected cancer. Also, surgery is recommended for severe colitis refractory to medical therapy.

• #1 Ulcerative Colitis: Treatment Options

  https://www.health.com/ulcerative-colitis-treatment-8628707

  Corticosteroids are powerful anti-inflammatory drugs that help manage moderate-to-severe UC. The medicines target body-wide inflammation and suppress the body’s immune response to reduce inflammation and control ulcerative colitis symptoms. […] Immunomodulators suppress the immune system to reduce inflammation. Your healthcare provider may prescribe immunomodulators if other treatments are ineffective or you frequently need corticosteroids. […] Targeted synthetic small molecules reduce inflammation by targeting and interrupting specific parts of the immune system involved in intestinal inflammation. They treat moderate-to-severe UC. […] Biologics treat moderate-to-severe ulcerative colitis. They target and inhibit specific proteins involved in the body’s inflammatory process. […] When symptoms don’t improve with medications or complications relating to UC develop, your healthcare provider may recommend surgery to treat ulcerative colitis.

• #1 IBD, Ulcerative Colitis and Crohn’s Disease Treatment | Patient Care

  https://weillcornell.org/ulcerative-colitis-and-crohn-s-disease-surgery

  Total abdominal colectomy with end ileostomy: The colon is surgically removed and an ileostomy is created through the abdominal wall (called a stoma). […] Proctocolectomy with ileal pouch-anal anastomosis: In this procedure, the colon and the rectum are removed, but the anus and anal sphincter muscles are preserved. The last portion of the small intestine (the ileum) is folded on itself and fashioned into a pouch, that acts as a reservoir to contain the stool prior to defecation. This eliminated the need for the external bag.

• #1 Ulcerative Colitis Treatments and Surgery

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/digestive-diseases-ulcerative-colitis-treatment

  Avoid fiber. […] Instead of three large meals, try eating five or six small meals a day. […] Drink lots of water every day. […] Some people get surgery to remove part or all of the colon. […] When you have an operation to remove your entire colon, a surgeon can either do it through a large incision or use a minimally invasive approach with small cuts and cameras which typically offer quicker recovery. […] A newer surgery, known as a pelvic pouch or ileal pouch-anal anastomosis (IPAA), doesn’t create a permanent opening. […] Doctors perform a procedure called a continent ileostomy (Kock pouch) if you want your external pouch converted to an internal one or if you can’t get the IPAA operation. […] You may consider these approaches in addition to what your doctor prescribes. […] Stress and anxiety are well-known triggers for many people with ulcerative colitis, so it is not surprising that mind-body relaxation techniques could help.

• #1 An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis

  https://www.mdpi.com/2077-0383/11/9/2302

  The gold standard approach includes total proctocolectomy and the creation of an ileal pouch anal anastomosis. […] The treatment of UC can be based on a wide range of therapies that should be decided on the basis of the localization of disease, severity of disease and concomitant conditions. […] In case of moderate-to-severe UC patients, CSs are the first-line treatment, and are increasingly more manageable thanks to different available formulations. […] In conclusion, the realization of well-designed clinical trials that comparatively evaluate the efficacy of biologics with different mechanisms of action, as well as the definition of specific therapeutic models through a multitarget approach, will allow, in the future, for the personalization of therapy in patients with UC.

• #1 Ulcerative Colitis: Symptoms, Causes, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/10351-ulcerative-colitis

  There are two kinds of surgery for ulcerative colitis. Both involve a proctocolectomy, surgery to remove all or part of your colon and rectum. […] The only cure for UC is surgery to remove your colon and rectum. Still, most people can manage UC with medications or surgery. With UC treatment, the goal is achieving and maintaining remission. Your healthcare provider can help you get there.

• #1 Crohn’s Disease and Ulcerative Colitis Treatment | Rush

  https://www.rush.edu/services/crohns-disease-and-ulcerative-colitis-care

  Your doctor will work with you to determine the right medications for you based on: […] Your overall health history […] The severity of your condition and symptoms […] The location of the inflammation in your GI tract […] Your personal preferences. […] Our goal for your treatment is to put your IBD into remission. […] However, about 10% to 20% of people each year experience Crohns disease and ulcerative colitis flareups. […] Surgery may be an option for you if: […] Medications are not effectively managing your symptoms […] Youre experiencing severe symptoms or complications. […] Surgery to remove your colon can actually cure ulcerative colitis. […] If you have surgery for Crohns disease, youll still need to take medications to reduce inflammation in your GI tract. […] Our IBD specialists lead and participate in research that is looking into novel ways to treat Crohns disease and ulcerative colitis.

• #1 Ulcerative Colitis: Current and Emerging Treatment Strategies

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7019865/

  Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 12 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the current and emerging treatment strategies for UC stratified according to disease severity. […] The goal of treatment is to achieve disease remission and prevent disease-related complications such as infection, surgery, and neoplasia, as well as preserve patients quality of life. […] The target for UC therapy is clinical remission defined as the resolution of rectal bleeding and diarrhea, and endoscopic remission defined as a Mayo endoscopic subscore of 0 or 1. […] Clinical and endoscopic remission in UC may be achieved with several classes of medication including mesalamine, immunomodulators, corticosteroids, biologics and, most recently, small molecules.

• #1 Ulcerative Colitis: Rapid Evidence Review | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p406.html

  Initiation of treatment begins with stratifying disease activity into mild vs. moderate to severe. […] Therapy and medication delivery modes are based on the location and extent of mucosal inflammation. […] The 2019 guidelines from the American College of Gastroenterology recommend treatment of mild ulcerative proctitis with rectal 5-amino-salicylic acid (5-ASA) therapies. […] Mild to moderate colitis should be treated with a combination of rectal 5-ASA enemas and oral 5-ASA therapies. […] Patients who are unresponsive to or intolerant of 5-ASA should use oral budesonide, extended release (Uceris; multimatrix formulation designed to deliver medication to the colonic mucosa). […] First-line therapy for moderate to severe ulcerative colitis is biologics. […] Biologic agents with or without glucocorticoids and immune modulators should be used to induce and maintain remission.

• #1 Ulcerative Colitis Treatment & Management: Approach Considerations, Treatment of Mild Disease, Treatment of Acute, Severe Disease

  https://emedicine.medscape.com/article/183084-treatment

  The treatment of ulcerative colitis (UC) is made on the basis of the disease stage (active, remission), extent (proctitis, distal colitis, left-sided colitis, pancolitis), and severity (mild, moderate, severe). In general, it relies on initial medical management with corticosteroids and anti-inflammatory agents, such as sulfasalazine, in conjunction with symptomatic treatment with antidiarrheal agents and rehydration. […] Surgery is contemplated when medical treatment fails or when a surgical emergency (eg, perforation of the colon) occurs. Surgical options include total colectomy (panproctocolectomy) and ileostomy, total colectomy, and ileoanal pouch reconstruction or ileorectal anastomosis. In an emergency situation, subtotal colectomy with end-ileostomy is recommended. […] Chronic UC is associated with an increase in the risk of carcinoma, and colonic carcinoma may easily be missed in the setting of UC. Patients with UC must be made aware of the significant risk of colon cancer, and surgical intervention in nonacute cases should be encouraged after 10 years of disease or when symptoms are refractory or steroid dependent.

• #1 Treatment for Ulcerative Colitis – NIDDK

  https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis/treatment

  Doctors may recommend or prescribe other treatments for symptoms or complications of ulcerative colitis. […] To treat mild pain, doctors may recommend acetaminophen instead of nonsteroidal anti-inflammatory drugs (NSAIDs). […] Doctors most often treat severe complications in a hospital. Doctors may give antibiotics, if severe ulcerative colitis or complications lead to infection, blood transfusions to treat severe anemia, IV fluids and electrolytes to prevent and treat dehydration. […] Doctors may treat life-threatening complications with surgery.

• #1 6 Natural Remedies to Help With Ulcerative Colitis

  https://www.healthline.com/health/ulcerative-colitis-take-control-natural-remedies

  Diet plays a significant role in managing UC symptoms and maintaining remission. Eliminating common trigger foods like whole grains, nuts, legumes, seeds, lactose, gluten, raw fruits and vegetables, and processed foods may help prevent or reduce symptoms. […] Treatment for UC aims to help: reduce inflammation, provide symptom relief, support remission, slow progression of the disease. […] Medications are the typical first-line treatment for UC. […] However, some natural remedies and suggestions like those below may complement these treatments and help you manage UC. […] A 2021 review notes that some diets for UC may also help you maintain or achieve remission, such as: Mediterranean diet, vegetarian or vegan diets, low FODMAP diet, paleo diet, low fat diet. […] However, the authors note that more research is needed to fully support the beneficial roles of these diets in managing UC.

• #1

  https://www.laparoscopyhospital.com/forum/forum.php?p=&cat_id=&tid=3562

  Ulcerative colitis is a chronic inflammatory bowel disease that can cause inflammation and sores (ulcers) in the colon and rectum. […] While there is no one-size-fits-all diet for managing ulcerative colitis, some people find that certain dietary changes can help alleviate symptoms. Here are some general guidelines: Low-Fiber Diet during Flare-ups: During flare-ups, a low-fiber diet may be easier on your digestive system. Foods like white rice, refined pasta, well-cooked vegetables (without skins), and lean proteins can be easier to tolerate. […] Medications: Aminosalicylates: These medications, such as mesalamine and sulfasalazine, are often used to reduce inflammation in the colon. Corticosteroids: In cases of moderate to severe inflammation, corticosteroids like prednisone may be prescribed for short-term use. Immunomodulators: Medications like azathioprine, 6-mercaptopurine, or methotrexate may be used to suppress the immune system. Biologics: Drugs like infliximab, adalimumab, and vedolizumab target specific components of the immune system to reduce inflammation. JAK inhibitors: Tofacitinib is an example of a Janus kinase (JAK) inhibitor that can be used in certain cases.

• #1 Ulcerative Colitis (UC): Symptoms, Causes, Treatment, and More

  https://www.medicalnewstoday.com/articles/163772

  A person with severe symptoms may need to spend time in the hospital. Hospital treatment can reduce the risk of malnutrition, dehydration, and life-threatening complications such as colon rupture. Treatment can involve intravenous (IV) fluids and medications. […] If other treatments do not provide relief or if a person experiences life-threatening complications, doctors may recommend colectomy surgery, where a surgeon removes part or all of the colon. […] Research suggests that 25 to 30% of people with UC may need surgical treatment. […] According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), some dietary measures may help relieve symptoms, including: eating smaller, more frequent meals, such as five or six small meals per day, drinking plenty of fluids, especially water, to prevent dehydration, avoiding caffeine and alcohol, which can both increase diarrhea, avoiding sodas, which can increase gas, keeping a food diary to identify foods that make symptoms worse.

• #1 Ulcerative Colitis Treatments and Surgery

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/digestive-diseases-ulcerative-colitis-treatment

  Many people with ulcerative colitis may not absorb enough of some vitamins or minerals from food because of their disease. […] Call your doctor right away if you have: Heavy, persistent diarrhea, Rectal bleeding with clots of blood in your stool, Constant pain and a high fever. […] Doctors treat ulcerative colitis with a combination of medicines, diet changes, and sometimes surgery.

• #1 Ulcerative Colitis – Digestive Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/digestive-disorders/inflammatory-bowel-diseases-ibd/ulcerative-colitis

  Ulcerative colitis treatment aims to control the inflammation, reduce symptoms, and replace any lost fluids and nutrients. […] Specific treatment depends on the severity of people’s symptoms. […] Iron supplements may offset anemia caused by ongoing blood loss in the stool. […] Usually, if the large intestine is swollen, people should eat a low-fiber diet (in particular, avoiding foods such as nuts, corn hulls, raw fruits, and vegetables) to reduce injury to the inflamed lining of the large intestine. However, a high-fiber diet should be resumed once the IBD flare resolves. […] A diet free of dairy products may decrease symptoms and is worth trying but does not need to be continued if no benefit is noted. […] All people who have ulcerative colitis should take calcium and vitamin D supplements.

• #1 Emerging Therapies for Ulcerative Colitis–Induced Pain

  https://www.uspharmacist.com/article/emerging-therapies-for-ulcerative-colitis-induced-pain

  Expressed on immune cells, integrins interact with cell-adhesion molecules to regulate leukocyte trafficking, which is well implicated in the etiopathogenesis of UC. […] Antidepressants are often prescribed for IBD patients for pain and GI upset related to psychological stress. […] In addition to standard pharmacotherapy, many UC patients require supplementation with vitamins and/or minerals. […] Omega-3 fatty acids are recommended in the treatment of some autoimmune diseases, such as rheumatoid arthritis. […] Probiotic use decreases the occurrence of acute complications and pain associated with UC. […] Psychological interventions may mitigate the side effects that are prevalent with traditional UC regimens, such as headache, nausea, abdominal pain, and diarrhea. […] Maintaining a healthy diet is generally associated with improved GI function. […] Regular exercise is beneficial for overall health by improving cardiovascular function and reducing inflammation and stress levels.

• #1 Natural remedies for ulcerative colitis: 7 options

  https://www.medicalnewstoday.com/articles/317744

  Natural remedies to help ease ulcerative colitis symptoms may include probiotics and herbal products such as aloe vera and wheatgrass. Dietary changes, exercise, acupuncture, and stress management may also help. […] Although natural remedies cannot cure ulcerative colitis (UC), they may help a person find relief from symptoms and flare-ups. A person can try natural remedies alongside standard treatments that a doctor prescribes. […] According to a 2022 research review, Lactobacillus and Bifidobacterium are the probiotics most commonly used to treat UC. For example, Lactobacillus rhamnossus GG and Bificobacterium longum BB536 may help ease UC symptoms. […] Additionally, an older 2011 study found that VSL3 was beneficial in treating mild to moderate UC when people used it alongside standard treatment.

• #1 Natural remedies for ulcerative colitis: 7 options

  https://www.medicalnewstoday.com/articles/317744

  The authors suggest that specific compounds in these herbal substances support immune system activity and provide antioxidants that can reduce inflammation. […] However, the authors do not recommend any of these substances as a stand-alone treatment. They suggest that people with UC use these products only as supplementary treatments alongside traditional treatments. […] A 2022 review suggests that curcumin may have an anti-inflammatory effect in people with UC. However, more research is necessary to determine its effects on gut microbiota. […] There is no cure for UC, but there are various treatment options, such as medications and surgery. A person can also try making dietary and lifestyle changes to ease symptoms and reduce flare-ups. Natural remedies, such as probiotics and herbal products, may also help.

• #1 Ulcerative Colitis: Rapid Evidence Review | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p406.html

  Systemic corticosteroids are effective in inducing remission, but dosages and treatment duration should be limited. […] Other options for inducing remission include tumor necrosis factoralpha antibodies, anti-integrin antibodies, anti-interleukin antibodies, and Janus kinase inhibitors. […] Fecal microbiota transplantation induces remission in some patients with ulcerative colitis, but current use is limited to clinical trials. […] Among patients with ulcerative colitis, 15% will ultimately need colectomy. […] Indications include failure of medical therapy, toxic megacolon, perforation, uncontrolled hemorrhage, or dysplasia/malignancy. […] One probiotic (VSL#3) modestly improves symptoms. […] A systematic review of six small studies found that curcumin (2 to 3 g daily) promotes clinical and endoscopic improvement when added to conventional therapy in patients with mild ulcerative colitis. […] Exercise and diet interventions help improve symptom burden and quality of life.

• #1 Natural treatments for ulcerative colitis | EBSCO Research Starters

  https://www.ebsco.com/research-starters/complementary-and-alternative-medicine/natural-treatments-ulcerative-colitis

  As natural remedies can interact with conventional treatments, it is advisable for patients to consult healthcare professionals before starting any new treatment regimen. […] Sulfasalazine is one of the most common medications for ulcerative colitis. Given either orally or as an enema, it can decrease symptoms and prevent recurrences. […] Medical treatment aims at reducing symptoms and inducing and maintaining remission. […] Probiotics might be useful for people with ulcerative colitis who have had part or all of the colon removed. […] Aloe was more effective than a placebo in inducing full or partial remission of symptoms. […] Researchers are interested in the use of phosphatidylcholine as a supportive treatment in severe ulcerative colitis. […] The substance curcumin (from the spice turmeric) has shown some promise for helping to maintain remission.

• #1 6 Natural Remedies to Help With Ulcerative Colitis

  https://www.healthline.com/health/ulcerative-colitis-take-control-natural-remedies

  However, 21 of 25 studies showed that probiotics helped promote and maintain remission for UC. […] Consider speaking with a healthcare professional before taking probiotics. They may recommend an alternative based on your health condition. […] A 2018 review found that exercise may have a variety of health benefits for people living with IBD, including: reducing disease progression and activity, boosting immune health, improving mood and quality of life, strengthening bones. […] The Centers for Disease Control and Prevention (CDC) recommends the following steps to help manage and relieve stress: getting regular physical activity, practicing deep breathing exercises, meditating, going outside, stretching, limiting or avoiding alcohol, if applicable, making time for a hobby, like reading or listening to music, speaking with a friend, family member, or healthcare professional about your feelings, joining a support group.

• #1 Treatment Options for Ulcerative Colitis

  https://www.everydayhealth.com/ulcerative-colitis/guide/treatment/

  Ulcerative colitis can be cured through surgery to remove the entire colon, but this course of treatment shouldnt be taken unless its medically necessary. […] Surgery may be necessary in the following situations: Disease that doesnt respond to multiple types of drug therapy, Severe complications, like toxic colitis, a ruptured colon, or extensive bleeding, Abnormal cells, or dysplasia, in the colon, which puts you at high risk for colon cancer. […] A number of lifestyle measures can help control ulcerative colitis symptoms and reduce the stress of living with this chronic condition. […] Curcumin A component of the spice turmeric, this supplement has an anti-inflammatory effect, and some research suggests it may help when taken along with conventional medication. […] Regularly engaging in meditation, tai chi, or yoga may reduce the stress of living with ulcerative colitis, according to the Crohns Colitis Foundation.

• #1 Ulcerative Colitis: Causes, Symptoms, and Treatment

  https://patient.info/digestive-health/inflammatory-bowel-disease/ulcerative-colitis

  Steroids work by reducing inflammation. If you develop a moderate or severe flare-up, a course of steroid tablets (corticosteroids) such as prednisolone will usually ease symptoms. […] Powerful medicines that suppress the immune system (immunosuppressants) may be used if symptoms persist despite the above treatments. […] Once an initial flare-up of symptoms has cleared, you will usually be advised to take a medicine each day to prevent further flare-ups. […] An aminosalicylate medicine, usually mesalazine, is commonly used to prevent flare-ups. […] Not everyone with ulcerative colitis has their symptoms well controlled with medication. About a quarter of people with ulcerative colitis need surgery at some stage. […] The common operation is to remove the colon and the rectum (the large intestine). […] A special diet is not usually needed. A normal, healthy, well-balanced diet is usually advised. […] Treatment for ulcerative colitis is an evolving field. Various new medicines are under investigation.

• #1 Ulcerative Colitis Treatment – Crohn’s & Colitis Australia (CCA)

  https://crohnsandcolitis.org.au/about-crohns-colitis/ulcerative-colitis/ulcerative-colitis-treatment/

  Research is still ongoing in many areas of CAM so it is important to always talk about your options with your doctor. […] Probiotics: Research suggests there may be a benefit to taking probiotics at inducing and maintaining remission in ulcerative colitis. […] Faecal Microbiota Transplant (FMT): Some studies suggest that FMT has the potential to induce remission in mild-to-moderate ulcerative colitis but more research in this area is needed. […] Medical Cannabis: More research is needed before using medical cannabis to treat UC is recommended.

• #1 Studies identify promising new treatments for ulcerative colitis | University of Chicago News

  https://news.uchicago.edu/story/studies-identify-promising-new-treatments-ulcerative-colitis

  According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic inflammatory disease of the large intestine. […] While treatments for the disease exist, not all patients respond to them. The results of two global studies one published in The New England Journal of Medicine and another in The Lancet offer hope to these individuals in the form of two new treatments. […] These studies describe the successful results of two new therapies that were effective in treating moderate to severe ulcerative colitis. […] The New England Journal of Medicine paper explored the use of a drug called tulisokibart as both a treatment for the disease and a companion diagnostic to determine response to the treatment. […] The study found that a significantly higher percentage of participants who received the treatment (26 percent) had clinical remission compared to placebo (1 percent).

• #1 Johnson & Johnson’s quest to develop effective IBD treatments

  https://www.jnj.com/innovation/inside-johnson-johnson-decades-long-quest-to-develop-effective-treatments-for-ibd

  Johnson Johnson researchers began investigating combination therapy, the use of two different medications at once, to improve IBD outcomes. […] Johnson Johnson launched a newly FDA-approved treatment for moderately to severely active UC, known as a dual-acting monoclonal antibody. […] Company researchers are looking into even more groundbreaking treatment approaches. […] An exciting treatment possibility involves multispecific antibodies, which are engineered to bind to more than one protein at a time. […] We’re trying to raise the efficacy bar even higher for patients who would otherwise not have any other options or would still be suffering, even though they’re on the best therapy available, says Dr. Lamous.

• #1 Reddit – The heart of the internet

  https://www.reddit.com/r/UlcerativeColitis/comments/w7ebvc/updated_list_of_treatment_options/

  Cyclosporine […] Tacrolimus (Astagraf XL, Envarsus XR, Prograf) […] TARGETED ORAL SMALL MOLECULES […] Tofacitinib (Xeljanz) […] Upadacitinib (Rinvoq) […] Filgotinib (Not available in the US) […] S1P RECEPTOR MODULATORS […] Ozanimod (Zeposia) […] SURGERY […] Proctocolectomy w/stoma […] Proctocolectomy w/j-pouch […] Ileal pouch anal anastomosis (IPAA) […] Continent ileostomy (Kock pouch) […] EXPERIMENTAL […] Fecal transplant […] Stem cell therapy […] Low dose Naltrexone […] Radical Induction Theory of UC Treatments […] Oral wide-spectrum antibiotic cocktails

• #1 Long-Term Maintenance Therapy for Ulcerative Colitis

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/long-term-maintenance-therapy-uc

  Theres no way to cure ulcerative colitis (UC). But there are now lots of ways to treat UC. The first goal of treatment is to get your UC into remission. When your UC is in remission, it means the inflammation is controlled and there are no ulcers in your colon so you shouldnt see any blood in your stools. You shouldnt need to find a bathroom more often than someone who doesnt have UC. If a doctor looks at your colon, there shouldnt be signs of UC there either. […] To keep your UC in remission, youll need long-term maintenance therapy. So the second goal of UC treatment after youre in remission is to do your best to make sure it stays that way. […] The type of medicine youll take to keep your UC in remission will depend on how your UC responds to different treatments and how severe it is.

• #1 Weighing the new approaches to treating Crohn’s and ulcerative colitis – Harvard Health

  https://www.health.harvard.edu/blog/weighing-the-new-approaches-to-treating-crohns-and-ulcerative-colitis-202210312841

  IBD treatment plans are complex, and are personalized for each patient. Your past medical history, disease severity and location, type of IBD, and response to past treatments are some of the many factors in deciding which medication is right for you. […] […] To assess your treatment, your doctor will continue to use a combination of your symptoms, blood work, stool tests, imaging, and endoscopy (upper endoscopy and/or colonoscopy) to determine if your treatment is working or needs adjustments. […] […] Sometimes this means changing the dosage or frequency of your current medication, adding a second medication, or starting you on a different type of treatment. The goal is to find the right medications for you for the long term, and to achieve clinical remission.

• #1 Long-Term Maintenance Therapy for Ulcerative Colitis

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/long-term-maintenance-therapy-uc

  Corticosteroids, often just called steroids, suppress the immune system, too. Theyre sometimes used to get a UC flare under control. But corticosteroids act on the whole immune system. They also have lots of side effects. Because of this, you shouldnt take steroids long-term, and doctors dont use them as maintenance therapy. […] Maintenance therapy can work well to keep your symptoms of UC at bay. But it probably doesnt mean youll never have a flare again. […] If you stop taking your medicine, theres obviously a better chance that your UC symptoms will come back. Most people with UC need maintenance therapy. Without maintenance therapy, its more likely you could need surgery in the future to treat your UC. […] Sometimes even if youre taking your maintenance medicine as you should, it may stop working. This might happen more with biologics. Sometimes you might also have side effects that make your maintenance medicines hard to keep taking.

• #1 Ulcerative Colitis Treatment: Surgery, Medication and Lifestyle | Cooper University Health Care

  https://www.cooperhealth.org/services/ulcerative-colitis/treatment

  Many clinical trials on ulcerative colitis test investigational drugs medications that are still being tested for safety, effectiveness, and tolerance and not yet approved by the U.S. Food and Drug Administration. […] Your doctor will likely recommend periodic laboratory tests to monitor your ulcerative colitis and determine whether any changes to your treatment plan are needed. […] As you work with your doctor to manage the treatment of your ulcerative colitis your disease, it is important to take steps to recognize triggers for your condition and make lifestyle changes that reduce the likelihood or severity of any flare-ups.

• #1 Ulcerative colitis (UC) clinical guidance toolkitAGA Logo_Horizontal

  https://gastro.org/clinical-guidance/guideline-toolkits/ulcerative-colitis-toolkit/

  Ulcerative colitis is a type of inflammatory bowel disease (IBD) that causes inflammation and sores in the large intestine. Symptoms include diarrhea, rectal bleeding, urgent and frequent need to go to the bathroom, and belly pain and cramps. […] Treatments for ulcerative colitis include medications, surgery or a combination. How to treat ulcerative colitis depends on the severity of the disease, past complications and response to earlier treatments. […] Guidelines for ulcerative colitis focus on how to use biomarkers for management of ulcerative colitis, therapies for ulcerative colitis, and how to care for patients who develop pouchitis after surgery. […] AGA suggests against using antibiotics for the primary prevention of pouchitis. […] AGA suggests a monitoring strategy that combines biomarkers and symptoms, rather than relying on symptoms alone.

• #1 Ulcerative Colitis Treatment Options

  https://www.crohnsandcolitis.com/ulcerative-colitis/treatment-options

  When inflammation is reduced in the colon lining, your tissue will show it during a colonoscopy. […] Youll have achieved endoscopic remission when theres little to no damage, or you have mild or inactive disease thats visible in your colon. […] Research suggests that there is a link between seeing improvement in inflammation and maintaining clinical remission meaning you have achieved longer-term symptom relief. […] These are some of the most commonly used prescription treatment options for UC. […] Taken either orally or rectally, these drugs work to decrease inflammation in the lining of the intestines and are usually used to treat mild to moderate ulcerative colitis. […] Biologics are designed to work on targeted parts of the immune system to reduce inflammation. […] Biologics are usually used for people with moderate to severe ulcerative colitis.

• #1 Ulcerative Colitis Treatment Options

  https://www.crohnsandcolitis.com/ulcerative-colitis/treatment-options

  For UC treatments, youve got options. […] Though there may not be a cure for moderate to severe ulcerative colitis (UC), there are several types of prescription treatment options available to help treat it. […] Finding the right treatment option can take time, but setting treatment goals can help you stay on track. […] Understanding the severity of your ulcerative colitis and the treatment options available can help you and your gastroenterologist work toward your treatment goals. […] Before you and your gastroenterologist discuss treatment plans, its important to discuss treatment goals. […] Controlling inflammation can help reduce ulcerative colitis symptoms and allow the colon lining to heal over time. […] Controlling inflammation can help you achieve clinical remission. […] This means you are experiencing little to no UC symptoms such as urgent bowel movements, bloody stools, and abdominal pain.

• #1 Ulcerative Colitis Treatment, Symptoms, Causes, Surgery

  https://www.emedicinehealth.com/ulcerative_colitis/article_em.htm

  Sometimes the doctor will recommend removing the colon if medical treatment fails or if the side effects of corticosteroids or other drugs threaten the patient’s health. […] What Are Natural Home Treatments for Ulcerative Colitis? Some patients will try alternative medicines to help treat ulcerative colitis. There is no evidence, as yet, that probiotics, fish oil, spices, and acupuncture are beneficial. […] Can Ulcerative Colitis Be Cured? Ulcerative colitis is not a fatal illness, but it is a lifelong illness. […] Maintenance medication has been shown to decrease flare-ups of ulcerative colitis. […] Surgery may be required in some patients, but it is not required in every patient with ulcerative colitis. […] Routine cancer screening is a must for those who do not undergo surgical removal of the colon.

• #2 Colitis: Symptoms, Causes, Diagnosis and treatment | MedPark Hospital

  http://www.medparkhospital.com/en-US/disease-and-treatment/colitis

  Treatment of colitis is according to the etiology, such as antibiotics or antiviral for infectious colitis, diet adjustment for allergic colitis, stop antibiotics for antibiotic-associated colitis, and anti-inflammatory drugs for IBD. […] Surgery can be an option for treating the complications of colitis, such as bowel gangrene from fulminant colitis or ischemic colitis, colonic obstruction, and massive bleeding which endoscopy or vascular intervention cannot control.

• #2 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  The goal of inflammatory bowel disease treatment is to reduce the inflammation that triggers symptoms. In the best cases, this may lead not only to symptom relief but also to long-term remission and reduced risk of complications. IBD treatment usually involves either medicines or surgery. […] Anti-inflammatory medicines are often the first step in the treatment of ulcerative colitis, typically for mild to moderate disease. Anti-inflammatories include aminosalicylates, such as mesalamine (Delzicol, Rowasa, others), balsalazide (Colazal) and olsalazine (Dipentum). […] Time-limited courses of corticosteroids also are used to induce remission. In addition to being anti-inflammatory, steroids are immunosuppressing. The type of medicine recommended depends on the area of the colon that’s affected.

• #2 Ulcerative Colitis: Causes, Symptoms, and Treatment

  https://patient.info/digestive-health/inflammatory-bowel-disease/ulcerative-colitis

  Ulcerative colitis is a disease where inflammation develops in the colon and the rectum (the large intestine). […] Treatment can usually ease a flare-up of symptoms. The disease can often be prevented from flaring up by taking medication, usually mesalazine, each day. Surgery to remove the colon is needed in some cases. […] The medicine advised may depend on the severity of the symptoms and the main site of the inflammation in the colon and the rectum (the large intestine). […] Topical treatments applied locally by an enema or suppository are widely used for treating ulcerative colitis, particularly aminosalicylate and steroid medicines. […] Aminosalicylates include mesalazine, olsalazine, balsalazide and sulfasalazine. They are recommended as the first option for treatment for mild-to-moderate flare-ups.

• #2 Ulcerative Colitis Treatment Options

  https://www.crohnsandcolitis.com/ulcerative-colitis/treatment-options

  When inflammation is reduced in the colon lining, your tissue will show it during a colonoscopy. […] Youll have achieved endoscopic remission when theres little to no damage, or you have mild or inactive disease thats visible in your colon. […] Research suggests that there is a link between seeing improvement in inflammation and maintaining clinical remission meaning you have achieved longer-term symptom relief. […] These are some of the most commonly used prescription treatment options for UC. […] Taken either orally or rectally, these drugs work to decrease inflammation in the lining of the intestines and are usually used to treat mild to moderate ulcerative colitis. […] Biologics are designed to work on targeted parts of the immune system to reduce inflammation. […] Biologics are usually used for people with moderate to severe ulcerative colitis.

• #2 Ulcerative Colitis Treatment & Management: Approach Considerations, Treatment of Mild Disease, Treatment of Acute, Severe Disease

  https://emedicine.medscape.com/article/183084-treatment

  As yet, no evidence suggests that regular endoscopic screening of patients with UC improves survival. However, the current standard of practice by many gastroenterologists is to continue screening these patients at regular intervals, owing to the risk of cancer development and possible legal implications if malignancy is not detected. […] In mild UC disease confined to the rectum, topical mesalazine (Asacol) given by suppository is the preferred therapy. […] Systemic steroids are indicated when the disease fails to quickly respond to aminosalicylates. […] In January 2013, the US Food and Drug Administration (FDA) approved an extended-release oral formulation of budesonide for the treatment of active mild-to-moderate UC in adults patients. […] Acute, severe UC (ie, 6 bloody bowel movements/day, with one of the following: fever 38C [100.4F], hemoglobin level 10.5 g/dL, heart rate 90 bpm, erythrocyte sedimentation rate 30 mm/h, or C-reactive protein level 30 mg/dL) requires hospitalization and treatment with intravenous high-dose corticosteroids (hydrocortisone 400 mg/d or methylprednisolone 60 mg/d).

• #2 Long-Term Maintenance Therapy for Ulcerative Colitis

  https://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/long-term-maintenance-therapy-uc

  Corticosteroids, often just called steroids, suppress the immune system, too. Theyre sometimes used to get a UC flare under control. But corticosteroids act on the whole immune system. They also have lots of side effects. Because of this, you shouldnt take steroids long-term, and doctors dont use them as maintenance therapy. […] Maintenance therapy can work well to keep your symptoms of UC at bay. But it probably doesnt mean youll never have a flare again. […] If you stop taking your medicine, theres obviously a better chance that your UC symptoms will come back. Most people with UC need maintenance therapy. Without maintenance therapy, its more likely you could need surgery in the future to treat your UC. […] Sometimes even if youre taking your maintenance medicine as you should, it may stop working. This might happen more with biologics. Sometimes you might also have side effects that make your maintenance medicines hard to keep taking.

• #2 Achieve Results with ENTYVIO® Treatment for Ulcerative Colitis

  https://www.entyvio.com/ulcerative-colitis

  46% of people administered ENTYVIO subcutaneously achieved remission at 1 year of treatment compared to 14% of people on placebo. […] ENTYVIO helped significantly more adult patients with moderate to severe UC than HUMIRA achieve remission at 1 year. […] 31% of people on ENTYVIO given as IV infusion achieved remission at 1 year compared to 23% of people on HUMIRA. […] ENTYVIO is a prescription medicine used in adults for the treatment of moderately to severely active ulcerative colitis (UC).

• #2 Studies identify promising new treatments for ulcerative colitis | University of Chicago News

  https://news.uchicago.edu/story/studies-identify-promising-new-treatments-ulcerative-colitis

  Across both groups, the researchers found that individuals who expressed the gene had a higher remission rate (32 percent) than placebo (11 percent). […] Rubin served as lead and corresponding author for a paper in The Lancet, which studied another drug called guselkumab, a monoclonal antibody that targets IL-23, the cytokine that drives many immune diseases, including ulcerative colitis. […] The study evaluated the efficacy and safety of guselkumab as a treatment for moderately to severely active ulcerative colitis. […] The researchers found that those taking the drug had significantly greater clinical remission (23 percent) than those receiving placebo (8 percent) at 12 weeks and were more likely to maintain remission at 44 weeks (50 percent versus 19 percent). […] Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. […] Its great to have another effective option for our patients, Rubin said.

• #2 Newly approved drug is a major advancement for patients with ulcerative colitis

  https://www.swedish.org/news/uf/685415274?streamid=7723912

  The new drug provides another option for patients who require an advanced treatment option or who desire an alternative to an injectable medication. […] Etrasimod is a major advance in the treatment of ulcerative colitis (UC), a chronic digestive disorder estimated to effect some 5 million people worldwide. […] Etrasimod helped 27% of patients achieve remission of ulcerative colitis symptoms after 12 weeks on the drug, versus about 7% for those taking a placebo; it was a major increase compared to remission rates of the most comparable drug currently available. […] The range of medications for UC includes anti-inflammatory drugs such as corticosteroids, immune system suppressors and biologics that target proteins made by the immune system. In severe cases, surgery may also be a treatment option. […] This medicine is a whole new class of molecule and a new mechanism of action that works on our immune system, adds Dr. Chiorean. It also works for patients for whom other drugs have failed.

• #2 Ulcerative Colitis – Digestive Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/digestive-disorders/inflammatory-bowel-diseases-ibd/ulcerative-colitis

  Immunomodulating medications modify the action of the body’s immune system, decreasing its activity. […] Biologic agents are medicines that are created by living organisms. […] To prevent symptoms from reappearing (that is, to maintain remission), people continue to take mesalamine by mouth or as an enema indefinitely because stopping this maintenance regimen often allows the disease to return (called relapse). […] About 30% of people with extensive ulcerative colitis require surgery. […] Complete removal of the large intestine, rectum, and anus (total proctocolectomy) permanently cures ulcerative colitis, restores life expectancy to normal, and eliminates the risk of colon cancer. […] However, various alternative procedures are now available, and the most common one is a procedure called proctocolectomy with ileal pouch-anal anastomosis (IPAA).

• #2 Ulcerative colitis – Wikipedia

  https://en.wikipedia.org/wiki/Ulcerative_colitis

  Several medications are used to treat symptoms and bring about and maintain remission, including aminosalicylates such as mesalazine or sulfasalazine, steroids, immunosuppressants such as azathioprine, and biologic therapy. […] Removal of the colon by surgery may be necessary if the disease is severe, does not respond to treatment, or if complications such as colon cancer develop. […] Removal of the colon and rectum generally cures the condition. […] The first-line maintenance medication for ulcerative colitis in remission is mesalazine (also known as mesalamine or 5-ASA). […] For patients with active disease limited to the left colon (descending colon) or proctitis, mesalazine is also the first-line agent, and a combination of suppositories and oral mesalazine may be tried. […] Adding corticosteroids such as prednisone is also common in active disease, especially if remission is not achieved through mesalazine monotherapy, but they are not used in long-term treatment as their risks then outweigh their benefits.

• #2 An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis

  https://www.mdpi.com/2077-0383/11/9/2302

  Even if non-biological drugs are the mainstay of treatment, in recent years, the introduction and diffusion of new biologic drugs has emerged as a valid treatment option for UC, also in its earliest stages. […] The aim of this review is to summarize current evidence regarding the first- and second-line approach for the management of UC, highlighting the controversial aspects of conventional drugs and the role of emerging strategies, including novel biologic and small molecule therapies. […] According to the most recent guidelines, the management of UC mainly depends on the localization (proctitis, left-sided, extensive) and severity of the disease. […] Recently, the development of different therapeutic options, such as biologic agents and small molecules, has completely called into question the traditional therapeutic algorithm, and a tailored approach should be recommended.

• #2 Ulcerative Colitis: Diagnosis and Treatment | AAFP

  https://www.aafp.org/pubs/afp/issues/2007/1101/p1323.html/1000

  Ulcerative colitis is a chronic disease with recurrent symptoms and significant morbidity. […] Treatment is based on the extent and severity of the disease. Rectal therapy with 5-aminosalicylic acid compounds is used for proctitis. More extensive disease requires treatment with oral 5-aminosalicylic acid compounds and oral corticosteroids. The side effects of steroids limit their usefulness for chronic therapy. Patients who do not respond to treatment with oral corticosteroids require hospitalization and intravenous steroids. Refractory symptoms may be treated with azathioprine or infliximab. Surgical treatment of ulcerative colitis is reserved for patients who fail medical therapy or who develop severe hemorrhage, perforation, or cancer. […] First-line medical therapies contain mesalamine (also known as 5-aminosalicylic acid [5-ASA]), which acts topically from the colonic lumen to suppress the production of numerous proinflammatory mediators.

• #2 Ulcerative Colitis – Digestive Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/digestive-disorders/inflammatory-bowel-diseases-ibd/ulcerative-colitis

  Ulcerative colitis treatment aims to control the inflammation, reduce symptoms, and replace any lost fluids and nutrients. […] Specific treatment depends on the severity of people’s symptoms. […] Iron supplements may offset anemia caused by ongoing blood loss in the stool. […] Usually, if the large intestine is swollen, people should eat a low-fiber diet (in particular, avoiding foods such as nuts, corn hulls, raw fruits, and vegetables) to reduce injury to the inflamed lining of the large intestine. However, a high-fiber diet should be resumed once the IBD flare resolves. […] A diet free of dairy products may decrease symptoms and is worth trying but does not need to be continued if no benefit is noted. […] All people who have ulcerative colitis should take calcium and vitamin D supplements.

• #2 Natural treatments for ulcerative colitis | EBSCO Research Starters

  https://www.ebsco.com/research-starters/complementary-and-alternative-medicine/natural-treatments-ulcerative-colitis

  As natural remedies can interact with conventional treatments, it is advisable for patients to consult healthcare professionals before starting any new treatment regimen. […] Sulfasalazine is one of the most common medications for ulcerative colitis. Given either orally or as an enema, it can decrease symptoms and prevent recurrences. […] Medical treatment aims at reducing symptoms and inducing and maintaining remission. […] Probiotics might be useful for people with ulcerative colitis who have had part or all of the colon removed. […] Aloe was more effective than a placebo in inducing full or partial remission of symptoms. […] Researchers are interested in the use of phosphatidylcholine as a supportive treatment in severe ulcerative colitis. […] The substance curcumin (from the spice turmeric) has shown some promise for helping to maintain remission.

• #2 Ulcerative Colitis: Rapid Evidence Review | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p406.html

  Systemic corticosteroids are effective in inducing remission, but dosages and treatment duration should be limited. […] Other options for inducing remission include tumor necrosis factoralpha antibodies, anti-integrin antibodies, anti-interleukin antibodies, and Janus kinase inhibitors. […] Fecal microbiota transplantation induces remission in some patients with ulcerative colitis, but current use is limited to clinical trials. […] Among patients with ulcerative colitis, 15% will ultimately need colectomy. […] Indications include failure of medical therapy, toxic megacolon, perforation, uncontrolled hemorrhage, or dysplasia/malignancy. […] One probiotic (VSL#3) modestly improves symptoms. […] A systematic review of six small studies found that curcumin (2 to 3 g daily) promotes clinical and endoscopic improvement when added to conventional therapy in patients with mild ulcerative colitis. […] Exercise and diet interventions help improve symptom burden and quality of life.

• #2 Current Pharmacologic Options and Emerging Therapeutic Approaches for the Management of Ulcerative Colitis: A Narrative Review | Published in Spartan Medical Research Journal

  https://smrj.scholasticahq.com/article/123397-current-pharmacologic-options-and-emerging-therapeutic-approaches-for-the-management-of-ulcerative-colitis-a-narrative-review

  Fecal microbiota transplantation (FMT) is an emerging therapeutic approach for UC. This treatment involves transferring stool from a healthy donor to the patients gastrointestinal tract to help rebalance gut microbiota and potentially alleviate UC symptoms. […] As a chronic illness, the main treatment goal in UC is to minimize the risk of flare-ups and suppress the formation of ulcers. UC necessitates long-term treatment to maintain a remission state.

• #2 Patients With Moderate-to-Severe Ulcerative Colitis May Find Significant Relief as New Treatment Option Shows Good Results in Clinical Trial | Mount Sinai – New York

  https://www.mountsinai.org/about/newsroom/2024/patients-with-moderate-to-severe-ulcerative-colitis-may-find-significant-relief-as-new-treatment-option-shows-good-results-in-clinical-trial

  Patients With Moderate-to-Severe Ulcerative Colitis May Find Significant Relief as New Treatment Option Shows Good Results in Clinical Trial […] A phase 2 trial of a monoclonal antibody known as tulisokibart for moderate-to-severe ulcerative colitis (UC) showed promising results for those who have not responded to conventional inflammatory bowel disease (IBD) treatment. […] The Mount Sinai-led trial was the first large study to demonstrate tulisokibart’s significant benefits in reducing inflammation and inducing remission in these patients. […] “Managing ulcerative colitis often requires a personalized approach and ongoing adjustments based on the patient’s response to therapy, especially for patients with more severe cases,” said Bruce E. Sands, MD, MS, Principal Investigator and the Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai. “Tulisokibart offers a new potential treatment option and addresses a critical gap in treatments for ulcerative colitis; this medication is showing promising results in regulating a patient’s immune response and promoting optimal healing.”

• #2 Ulcerative Colitis: Symptoms, Causes, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/10351-ulcerative-colitis

  Ulcerative colitis (UC) is a chronic condition that happens when you have inflammation in your colon. […] Treatments include medication and surgery. […] The goal of treatment is to put you into remission if you’re experiencing a flare-up or help you maintain remission if you’re not currently experiencing symptoms. Treatment options include medications and surgery. […] Healthcare providers use several medications (alone or in combination) to calm inflammation in your large intestine. Reducing the swelling and irritation lets the tissue heal. It can also relieve your symptoms so you have less pain and diarrhea. […] Medications for UC include: […] Surgery is an option if medications aren’t working or if you’re experiencing serious complications. About 30% of people with ulcerative colitis need surgery at some point.

• #2 An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis

  https://www.mdpi.com/2077-0383/11/9/2302

  The gold standard approach includes total proctocolectomy and the creation of an ileal pouch anal anastomosis. […] The treatment of UC can be based on a wide range of therapies that should be decided on the basis of the localization of disease, severity of disease and concomitant conditions. […] In case of moderate-to-severe UC patients, CSs are the first-line treatment, and are increasingly more manageable thanks to different available formulations. […] In conclusion, the realization of well-designed clinical trials that comparatively evaluate the efficacy of biologics with different mechanisms of action, as well as the definition of specific therapeutic models through a multitarget approach, will allow, in the future, for the personalization of therapy in patients with UC.

• #2 Crohn’s Disease and Ulcerative Colitis Treatment | Rush

  https://www.rush.edu/services/crohns-disease-and-ulcerative-colitis-care

  Ulcerative colitis is inflammation limited to your colon and rectum. […] Like Crohns disease, ulcerative colitis can be well-managed and go into remission with the right treatments. It can also be cured with surgery to remove the entire colon. […] Your Rush team will work with you to find the right Crohns disease or ulcerative colitis treatment or combination of treatments for you. Your treatment will focus on: […] Addressing and easing your symptoms […] Getting your Crohns disease or ulcerative colitis into remission […] Improving your quality of life […] Lowering your risk for complications and hospitalization. […] Medications are the most effective treatment for Crohns disease and ulcerative colitis. […] Some of the most promising medications are biologics, also known as immunotherapies.

• #3 NEJM: Results From Targeted Therapy for Ulcerative Colitis

  https://www.cedars-sinai.org/newsroom/nejm-results-from-targeted-therapy-for-ulcerative-colitis-study/

  The study evaluated a therapy developed by Cedars-Sinai clinician-scientists called tulisokibart (previously PRA023) a man-made monoclonal antibody that acts like endogenous antibodies. […] It is designed to target and block a protein called TL1A, which can contribute to the severity of ulcerative colitis. […] Unlike other IBD treatments that can exacerbate inflammation or suppress the body’s natural anti-inflammatory responses, our findings suggest that tulisokibart modulates inflammation and the body’s anti-inflammatory mechanisms, Targan said. […] This dual action could lead to more balanced and effective management of ulcerative colitis. […] A Phase III study will further examine safety and test effectiveness of tulisokibart in patients who take it longer than 12 weeks. […] McGovern, who was recently awarded the prestigious Sherman Prize for his pioneering work in advancing understanding of the genetic architecture of IBD in diverse populations, says the uniqueness of this target and the way tulisokibart was designed to interact with that target represent significant advancements in how clinicians approach IBD treatment. […] We’ve devoted our careers to getting better treatments to IBD patients, and now we’re closer than ever to helping all patients with ulcerative colitis get their disease into remission so they can get back to enjoying life.

Zobacz więcej